Search

everythinglearnresearchcommunity

for

Search:↓

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

ITK inhibitors may effectively treat alopecia areata.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Ritlecitinib is an effective new treatment for Alopecia Areata.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The ILDS Newsletter reported on efforts to support albinism patients in Tanzania and dermatological conferences.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Apremilast improved symptoms in patients with severe skin conditions.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

Restoring phenylalanine levels improved skin and hair symptoms in a PKU infant.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.